Kreusel K-M, Bechrakis N, Wiegel T, Emmerlich T, Foerster M H
Augenklinik Berlin-Marzahn, Berlin.
Ophthalmologe. 2003 Aug;100(8):618-22. doi: 10.1007/s00347-002-0768-9.
Choroidal metastasis (CM) is the most common malignant intraocular tumor. The aim of this study was the characterization of the ophthalmoscopic aspect, the underlying tumor disease and differential diagnosis of this entity.
Retrospective observational case series.
A total of 71 consecutive patients with CM were evaluated. Special attention was given to ocular symptoms, the ophthalmoscopic and sonographic aspects and the characteristics of the underlying tumor disease. All patients had undergone screening (CCT, CT of thorax and abdomen; bone scintigraphy) for the primary tumor and further organ metastases.
Of the patients 95% had symptomatic CM, in 5% of the patients CM was detected by chance, 60% had a single CM, 40% showed multiple (2-14) lesions and 18% ( n=13) had no history of tumor disease. In 12 of these patients lung cancer could be diagnosed. In 53% of the patients the primary tumor was breast cancer, in 26% lung cancer, in 3% kidney cancer, bowel cancer, choroidal or cutaneous melanoma and in single patients cervical, ovarian, thymus or prostate cancer. In one patient who died from disseminated metastases, no definite primary tumor could be detected. Of the patients 96% had further metastases, CM occurred with a mean interval after diagnosis of the primary of 9 months in lung cancer and 68 months in breast cancer. CM was the first clinical sign of tumor disease in 58% of patients with lung cancer and the first clinical sign of metastatic disease in 28% of patients with breast cancer.
Choroidal metastasis occurs almost exclusively in metastatic disease. In breast cancer it typically occurs years after diagnosis of the primary tumor and may be the first sign of metastatic disease. In lung cancer choroidal metastasis may be the first sign of the tumor disease.
脉络膜转移瘤(CM)是最常见的眼内恶性肿瘤。本研究的目的是对该疾病的眼底表现、潜在肿瘤疾病以及鉴别诊断进行特征描述。
回顾性观察病例系列研究。
共评估了71例连续性CM患者。特别关注眼部症状、眼底及超声表现以及潜在肿瘤疾病的特征。所有患者均接受了针对原发肿瘤及其他器官转移灶的筛查(胸部和腹部计算机断层扫描(CCT、CT);骨闪烁显像)。
95%的患者患有症状性CM,5%的患者CM为偶然发现,60%的患者有单个CM,40%的患者表现为多个(2 - 14个)病灶,18%(n = 13)的患者无肿瘤疾病史。其中12例患者可诊断为肺癌。53%的患者原发肿瘤为乳腺癌,26%为肺癌,3%为肾癌、肠癌、脉络膜或皮肤黑色素瘤,单例患者为宫颈癌、卵巢癌、胸腺癌或前列腺癌。1例死于播散性转移的患者未检测到明确的原发肿瘤。96%的患者有其他转移灶,CM在肺癌患者中发生的平均间隔时间为原发肿瘤诊断后9个月,在乳腺癌患者中为68个月。CM是58%肺癌患者肿瘤疾病的首个临床症状,是28%乳腺癌患者转移疾病的首个临床症状。
脉络膜转移瘤几乎仅发生于转移性疾病。在乳腺癌中,它通常在原发肿瘤诊断数年之后出现,可能是转移疾病的首个症状。在肺癌中,脉络膜转移瘤可能是肿瘤疾病的首个症状。